Age-related macular degeneration (AMD) is the leading cause of legal blindness in the
industrialized world. AMD is characterized by accumulation of extracellular deposits, namely …

Objective To systematically review the evidence on dietary ω-3 fatty acid and fish intake in
the primary prevention of age-related macular degeneration (AMD). Methods Seven …

Objective To evaluate the effectiveness of dietary antioxidants in the primary prevention of
age related macular degeneration (AMD). Design Systematic review and meta-analysis …

Advanced age-related macular degeneration (AMD) is the leading cause of blindness in the
elderly, with limited therapeutic options. Here we report on a study of> 12 million variants …

Abstract Malattia Leventinese (ML) and Doyne honeycomb retinal dystrophy (DHRD) refer to
two autosomal dominant diseases characterized by yellow-white deposits known as drusen …

Objective To evaluate the safety and efficacy of individualized ranibizumab treatment in
patients with neovascular age-related macular degeneration. Design Twelve-month, phase …

We present a novel framework combining convolutional neural networks (CNN) and graph
search methods (termed as CNN-GS) for the automatic segmentation of nine layer …

Purpose To test the hypothesis that tolerating some subretinal fluid (SRF) in patients with
neovascular age-related macular degeneration (nAMD) treated with ranibizumab using a …

Despite significant progress in the identification of genetic loci for age-related macular
degeneration (AMD), not all of the heritability has been explained. To identify variants which …

Retinal visual prostheses (“bionic eyes”) have the potential to restore vision to blind or
profoundly vision-impaired patients. The medical bionic technology used to design …